Handelsbanken Fonder AB Has $1.22 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Handelsbanken Fonder AB raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,674 shares of the company’s stock after buying an additional 1,400 shares during the period. Handelsbanken Fonder AB’s holdings in Acadia Healthcare were worth $1,219,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ACHC. Headlands Technologies LLC acquired a new position in Acadia Healthcare during the 3rd quarter valued at about $25,000. Fifth Third Bancorp boosted its position in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare in the 3rd quarter valued at $96,000. Oak Thistle LLC bought a new position in Acadia Healthcare during the 4th quarter valued at $235,000. Finally, Advisor Partners II LLC boosted its holdings in Acadia Healthcare by 7.5% during the 3rd quarter. Advisor Partners II LLC now owns 3,351 shares of the company’s stock worth $236,000 after acquiring an additional 234 shares during the last quarter.

Insider Activity

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.80% of the stock is owned by company insiders.

Acadia Healthcare Trading Up 0.3 %

Shares of ACHC opened at $73.59 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a market cap of $6.80 billion, a P/E ratio of -294.36, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31. Acadia Healthcare Company, Inc. has a fifty-two week low of $66.49 and a fifty-two week high of $87.77. The business has a 50-day moving average of $78.07 and a 200 day moving average of $77.74.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. During the same period in the prior year, the company posted $0.70 EPS. Acadia Healthcare’s revenue was up 10.0% compared to the same quarter last year. As a group, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. UBS Group raised their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a report on Friday, January 5th. Mizuho lifted their price target on Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, March 6th. Barclays initiated coverage on Acadia Healthcare in a research report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 target price for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $92.00.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.